{"id":624,"date":"2022-02-22T19:50:08","date_gmt":"2022-02-22T19:50:08","guid":{"rendered":"https:\/\/glossaire.myeloma.ca\/?glossaire=mdr-resistance-a-plusieurs-medicaments"},"modified":"2022-02-22T19:50:08","modified_gmt":"2022-02-22T19:50:08","slug":"mdr-resistance-a-plusieurs-medicaments","status":"publish","type":"glossary","link":"https:\/\/myeloma.ca\/fr\/glossaire\/mdr-resistance-a-plusieurs-medicaments\/","title":{"rendered":"MDR (r\u00e9sistance \u00e0 plusieurs m\u00e9dicaments)"},"content":{"rendered":"<p>R\u00e9sistance au traitement standard, g\u00e9n\u00e9ralement associ\u00e9e \u00e0 une r\u00e9sistance \u00e0 l\u2019Adriamycine et \u00e0 la Vincristine, deux m\u00e9dicaments utilis\u00e9s en chimioth\u00e9rapie. La r\u00e9sistance est caus\u00e9e par une accumulation de glycoprot\u00e9ine-P dans la membrane cellulaire ext\u00e9rieure de la cellule du my\u00e9lome. Par cons\u00e9quent, au lieu de s\u2019accumuler dans la cellule my\u00e9lomateuse pour la tuer, les m\u00e9dicaments sont rejet\u00e9s en dehors de celle-ci.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>R\u00e9sistance au traitement standard, g\u00e9n\u00e9ralement associ\u00e9e \u00e0 une r\u00e9sistance \u00e0 l\u2019Adriamycine et \u00e0 la Vincristine, deux m\u00e9dicaments utilis\u00e9s en chimioth\u00e9rapie. La r\u00e9sistance est caus\u00e9e par une accumulation de glycoprot\u00e9ine-P dans la membrane cellulaire ext\u00e9rieure de la cellule du my\u00e9lome. Par cons\u00e9quent, au lieu de s\u2019accumuler dans la cellule my\u00e9lomateuse pour la tuer, les m\u00e9dicaments sont [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"template":"","glossary-cat":[],"class_list":["post-624","glossary","type-glossary","status-publish","hentry"],"acf":[],"aioseo_notices":[],"related_terms":"","external_url":"","internal_reference_id":"","_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/glossary\/624","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/glossary"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/glossary"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":0,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/glossary\/624\/revisions"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=624"}],"wp:term":[{"taxonomy":"glossary-cat","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/glossary-cat?post=624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}